Another Delay for Reloxin
From Bloomberg“April 14 (Bloomberg) — Competition for the Botox shot, America? s most popular cosmetic procedure, was delayed as U. S. drug regulators discuss labeling and a strategy for evaluating and mitigating risks of the new wrinkle smoother. Medicis Pharmaceuti...
View More
